These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 23801834)

  • 1. Human liver tissue metabolic profiling research on hepatitis B virus-related hepatocellular carcinoma.
    Liu SY; Zhang RL; Kang H; Fan ZJ; Du Z
    World J Gastroenterol; 2013 Jun; 19(22):3423-32. PubMed ID: 23801834
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [High-performance liquid chromatography-mass spectrometry-based serum metabolic profiling in patients with HBV-related hepatocellular carcinoma].
    Zhang L; Fan Z; Kang H; Wang Y; Liu S; Shan Z
    Nan Fang Yi Ke Da Xue Xue Bao; 2019 Jan; 39(1):49-56. PubMed ID: 30692066
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Urinary nuclear magnetic resonance spectroscopy of a Bangladeshi cohort with hepatitis-B hepatocellular carcinoma: A biomarker corroboration study.
    Cox IJ; Aliev AE; Crossey MM; Dawood M; Al-Mahtab M; Akbar SM; Rahman S; Riva A; Williams R; Taylor-Robinson SD
    World J Gastroenterol; 2016 Apr; 22(16):4191-200. PubMed ID: 27122669
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detection of hepatocellular carcinoma in hepatitis C patients: biomarker discovery by LC-MS.
    Bowers J; Hughes E; Skill N; Maluccio M; Raftery D
    J Chromatogr B Analyt Technol Biomed Life Sci; 2014 Sep; 966():154-62. PubMed ID: 24666728
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabolite profiling analysis of hepatitis B virus-induced liver cirrhosis patients with minimal hepatic encephalopathy using gas chromatography-time-of-flight mass spectrometry and ultra-performance liquid chromatography-quadrupole-time-of-flight mass spectrometry.
    Huang G; Xie S; Wang M; Mao D; Huang G; Huang J; Liu X; Zhang R; Xie J; Huang LJ; Cheng C; Yao F; Zhong Y; Lin L; Yao C
    Biomed Chromatogr; 2023 Jan; 37(1):e5529. PubMed ID: 36250932
    [TBL] [Abstract][Full Text] [Related]  

  • 6. LC-MS based serum metabolomics for identification of hepatocellular carcinoma biomarkers in Egyptian cohort.
    Xiao JF; Varghese RS; Zhou B; Nezami Ranjbar MR; Zhao Y; Tsai TH; Di Poto C; Wang J; Goerlitz D; Luo Y; Cheema AK; Sarhan N; Soliman H; Tadesse MG; Ziada DH; Ressom HW
    J Proteome Res; 2012 Dec; 11(12):5914-23. PubMed ID: 23078175
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Analysis of urine metabolic profile in patients with hepatocellular carcinoma].
    Chen X; Zhang L; Wu YJ; Liu SY; Liu HP
    Zhonghua Gan Zang Bing Za Zhi; 2021 Aug; 29(8):788-793. PubMed ID: 34517462
    [No Abstract]   [Full Text] [Related]  

  • 8. Identification of 1-Methylnicotinamide as a specific biomarker for the progression of cirrhosis to hepatocellular carcinoma.
    Zhang S; Tuo P; Ji Y; Huang Z; Xiong Z; Li H; Ruan C
    J Cancer Res Clin Oncol; 2024 Jun; 150(6):310. PubMed ID: 38890166
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum and urine metabolite profiling reveals potential biomarkers of human hepatocellular carcinoma.
    Chen T; Xie G; Wang X; Fan J; Qiu Y; Zheng X; Qi X; Cao Y; Su M; Wang X; Xu LX; Yen Y; Liu P; Jia W
    Mol Cell Proteomics; 2011 Jul; 10(7):M110.004945. PubMed ID: 21518826
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolite variations between acute-on-chronic liver failure and chronic liver failure caused by hepatitis B virus based on ultra-performance liquid chromatography mass spectrometry.
    Lian J; Li X; Wang Y; Yang J; Liu W; Ma J; Chen D; Li L; Huang J
    Biomed Pharmacother; 2016 Dec; 84():994-1000. PubMed ID: 27768929
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tissue and serum metabolite profiling reveals potential biomarkers of human hepatocellular carcinoma.
    Han J; Qin WX; Li ZL; Xu AJ; Xing H; Wu H; Zhang H; Wang MD; Li C; Liang L; Quan B; Yan WT; Shen F; Wu MC; Yang T
    Clin Chim Acta; 2019 Jan; 488():68-75. PubMed ID: 30389456
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of novel biomarkers of hepatocellular carcinoma by high-definition mass spectrometry: Ultrahigh-performance liquid chromatography quadrupole time-of-flight mass spectrometry and desorption electrospray ionization mass spectrometry imaging.
    Nagai K; Uranbileg B; Chen Z; Fujioka A; Yamazaki T; Matsumoto Y; Tsukamoto H; Ikeda H; Yatomi Y; Chiba H; Hui SP; Nakazawa T; Saito R; Koshiba S; Aoki J; Saigusa D; Tomioka Y
    Rapid Commun Mass Spectrom; 2020 Apr; 34 Suppl 1(Suppl 1):e8551. PubMed ID: 31412144
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metabolic profiling of hepatitis B virus-related hepatocellular carcinoma with diverse differentiation grades.
    Zhang L; Huang Y; Lian M; Fan Z; Tian Y; Wang Y; Kang H; Liu S; Liu S; Li T; Shan Z
    Oncol Lett; 2017 Mar; 13(3):1204-1210. PubMed ID: 28454235
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The serum metabolic profiles of different Barcelona stages hepatocellular carcinoma associated with hepatitis B virus.
    Zhang L; Wu GY; Wu YJ; Liu SY
    Oncol Lett; 2018 Jan; 15(1):956-962. PubMed ID: 29399157
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fecal metabolome profiling of liver cirrhosis and hepatocellular carcinoma patients by ultra performance liquid chromatography-mass spectrometry.
    Cao H; Huang H; Xu W; Chen D; Yu J; Li J; Li L
    Anal Chim Acta; 2011 Apr; 691(1-2):68-75. PubMed ID: 21458633
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metabolic perturbations prior to hepatocellular carcinoma diagnosis: Findings from a prospective observational cohort study.
    Stepien M; Keski-Rahkonen P; Kiss A; Robinot N; Duarte-Salles T; Murphy N; Perlemuter G; Viallon V; Tjønneland A; Rostgaard-Hansen AL; Dahm CC; Overvad K; Boutron-Ruault MC; Mancini FR; Mahamat-Saleh Y; Aleksandrova K; Kaaks R; Kühn T; Trichopoulou A; Karakatsani A; Panico S; Tumino R; Palli D; Tagliabue G; Naccarati A; Vermeulen RCH; Bueno-de-Mesquita HB; Weiderpass E; Skeie G; Ramón Quirós J; Ardanaz E; Mokoroa O; Sala N; Sánchez MJ; Huerta JM; Winkvist A; Harlid S; Ohlsson B; Sjöberg K; Schmidt JA; Wareham N; Khaw KT; Ferrari P; Rothwell JA; Gunter M; Riboli E; Scalbert A; Jenab M
    Int J Cancer; 2021 Feb; 148(3):609-625. PubMed ID: 32734650
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metabonomic profiles discriminate hepatocellular carcinoma from liver cirrhosis by ultraperformance liquid chromatography-mass spectrometry.
    Wang B; Chen D; Chen Y; Hu Z; Cao M; Xie Q; Chen Y; Xu J; Zheng S; Li L
    J Proteome Res; 2012 Feb; 11(2):1217-27. PubMed ID: 22200553
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeted metabolic profiling of hepatocellular carcinoma and hepatitis C using LC-MS/MS.
    Baniasadi H; Gowda GA; Gu H; Zeng A; Zhuang S; Skill N; Maluccio M; Raftery D
    Electrophoresis; 2013 Oct; 34(19):2910-7. PubMed ID: 23856972
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Application of liquid chromatography-mass spectrometry in the study of metabolic profiling of cirrhosis in different grades].
    Du Z; Zhang L; Liu S
    Se Pu; 2011 Apr; 29(4):314-9. PubMed ID: 21770240
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of B7-H4 and hepatitis B virus X in hepatitis B virus-related hepatocellular carcinoma.
    Hong B; Qian Y; Zhang H; Sang YW; Cheng LF; Wang Q; Gao S; Zheng M; Yao HP
    World J Gastroenterol; 2016 May; 22(18):4538-46. PubMed ID: 27182163
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.